Which IV medication should be treated as a hazardous spill?

Doxorubicin should be treated as a hazardous spill due to its classification as a cytotoxic chemotherapy agent. Such medications are known to pose significant risks due to their potent effects on rapidly dividing cells, which can lead to severe toxicity not only for patients but also for healthcare providers who may come into contact with them. When handling or administering doxorubicin, special precautions are necessary to prevent exposure, including the use of personal protective equipment and proper disposal methods.

The handling protocols related to hazardous medications are in place to ensure that these agents do not pose a risk to the environment or the safety of individuals involved in patient care. This is why it is critical to follow specific procedures for cleaning up spills of doxorubicin, as exposure can result in serious health consequences. In contrast, other medications mentioned in the options do not carry the same hazardous classification and thus do not require the same level of precaution in the event of a spill.